[go: up one dir, main page]

WO2011056545A3 - Antimicrobial ionic liquids - Google Patents

Antimicrobial ionic liquids Download PDF

Info

Publication number
WO2011056545A3
WO2011056545A3 PCT/US2010/054048 US2010054048W WO2011056545A3 WO 2011056545 A3 WO2011056545 A3 WO 2011056545A3 US 2010054048 W US2010054048 W US 2010054048W WO 2011056545 A3 WO2011056545 A3 WO 2011056545A3
Authority
WO
WIPO (PCT)
Prior art keywords
ionic liquids
antimicrobial
antimicrobial ionic
species
pared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2010/054048
Other languages
French (fr)
Other versions
WO2011056545A2 (en
Inventor
Mark W. Grinstaff
Michel Wathier
George A. O'toole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Publication of WO2011056545A2 publication Critical patent/WO2011056545A2/en
Publication of WO2011056545A3 publication Critical patent/WO2011056545A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Certain aspects of the present invention relate to compositions, formulations, and use of ionic liquids as antimicrobial agent (e.g. as antibacterial and/or antifungal agents). In certain embodiments, the ionic liquids can be pared with one or more singly charge species or with one or more multi-charged species.
PCT/US2010/054048 2009-10-26 2010-10-26 Antimicrobial ionic liquids Ceased WO2011056545A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25495709P 2009-10-26 2009-10-26
US61/254,957 2009-10-26

Publications (2)

Publication Number Publication Date
WO2011056545A2 WO2011056545A2 (en) 2011-05-12
WO2011056545A3 true WO2011056545A3 (en) 2011-09-22

Family

ID=43970658

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/054048 Ceased WO2011056545A2 (en) 2009-10-26 2010-10-26 Antimicrobial ionic liquids

Country Status (1)

Country Link
WO (1) WO2011056545A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015066647A2 (en) * 2013-11-03 2015-05-07 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
WO2018044920A1 (en) 2016-08-29 2018-03-08 The Regents Of The University Of California Topical formulations based on ionic species for skin treatment
WO2018075614A1 (en) 2016-10-18 2018-04-26 Marquette University Composite materials containing structural polymers and photoreactive nitric odide releasing agents and uses thereof for wound dressings
US10828265B2 (en) 2016-12-09 2020-11-10 The Regents Of The University Of California Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
WO2018222924A1 (en) 2017-06-01 2018-12-06 Arizona Board Of Regents On Behalf Of Northern Arizona University Antibiofilm formulations
EP3739006B1 (en) 2019-05-15 2025-10-22 The Hong Kong University of Science and Technology Ionic liquid-based coating and method of making articles coated with the same
WO2020257316A1 (en) 2019-06-17 2020-12-24 Marquette University Materials based on natural pollen grains and uses thereof
US20230329988A1 (en) * 2020-06-26 2023-10-19 Cage Bio Inc. Sanitizing compositions containing ionic liquid
US11781106B1 (en) * 2021-03-01 2023-10-10 United States Of America As Represented By The Secretary Of The Air Force Intracellular non-genetic modification of microorganisms using protein ionic liquids
CN117717892B (en) * 2024-02-08 2024-04-30 四川益能康生环保科技有限公司 Composite desulfurizing agent for absorbing sulfur dioxide and preparation process thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077519A1 (en) * 2002-06-28 2004-04-22 The Procter & Gamble Co. Ionic liquid based products and method of using the same
US20070167332A1 (en) * 1999-09-07 2007-07-19 Akzo Nobel Surface Chemistry Llc Quaternary ammonium salts as thickening agents for aqueous systems
US20070225191A1 (en) * 2006-03-27 2007-09-27 The Procter & Gamble Company Methods for modifying bioplymers in ionic liquids
US20080070966A1 (en) * 2006-06-14 2008-03-20 Elder Stewart T Anti-microbial compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167332A1 (en) * 1999-09-07 2007-07-19 Akzo Nobel Surface Chemistry Llc Quaternary ammonium salts as thickening agents for aqueous systems
US20040077519A1 (en) * 2002-06-28 2004-04-22 The Procter & Gamble Co. Ionic liquid based products and method of using the same
US20070225191A1 (en) * 2006-03-27 2007-09-27 The Procter & Gamble Company Methods for modifying bioplymers in ionic liquids
US20080070966A1 (en) * 2006-06-14 2008-03-20 Elder Stewart T Anti-microbial compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KATHRYN M. DOCHERTY ET AL.: "Toxicity and antimicrobial activity of imidazolium and pyridinium ionic liquids", GREEN CHEMISTRY, vol. 7, 2005, pages 185 - 189 *

Also Published As

Publication number Publication date
WO2011056545A2 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
WO2011056545A3 (en) Antimicrobial ionic liquids
WO2011030158A3 (en) Antimicrobial composition
WO2008144014A3 (en) Bioactive acid agrichemical compositions and use thereof
CA3126679C (en) Topical sanitizing formulations and uses thereof
IL249141B (en) Parasiticidal compositions comprising multiple active agents, methods and uses thereof
GEP20156376B (en) Solid herbicide compositions with built-in adjuvant
WO2008089822A3 (en) Antimicrobial composition comprising zinc oxide, barium sulphate and silver ions
WO2008104310A3 (en) Antimicrobial compositions
WO2013103832A3 (en) Personal care compositions containing ionic silicone and film-forming agent
WO2011091322A3 (en) Antimicrobial agent comprising peroxide, alcohol and chelating agent
WO2008085578A3 (en) Anti-microbial compositions and devices and methods of using the same
EP2217614A4 (en) Antimicrobial compositions, formulations and uses thereof
WO2011150457A3 (en) Haematopoietic-prostaglandin d2 synthase inhibitors
MY173847A (en) Disinfectant compositions and uses thereof
WO2011038316A3 (en) Compositions of dibromomalonamide and their use as biocides
WO2011094504A3 (en) Antimicrobial sinus irrigation compositions, methods, and devices
WO2012148720A3 (en) Anti-microbial peptides and methods of use thereof
EP2312952A4 (en) ANTIMICROBIAL COMPOSITION
WO2011119954A3 (en) Antimicrobial silica composites
MX2015008373A (en) Antimicrobial peptides, compositions comprising the same and uses thereof.
WO2014186344A3 (en) Methods and agents for treating tyrosinase-positive albinism
WO2010127335A3 (en) Antimicrobial zinc pyrithione composition and method
MX342592B (en) Compositions of dibromomalonamide and their use as biocides.
PH12016501448A1 (en) Antifungal composition
WO2012013505A3 (en) Composition comprising oxalysine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10828844

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10828844

Country of ref document: EP

Kind code of ref document: A2